Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Xujun You
Observed names:
Xujun J. You,
You, Xujun
Institutions:
Guangzhou University of Chinese Medicine,
Hunan University of Traditional Chinese Medicine,
Beijing University of Chinese Medicine,
Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine
Observed institutions:
Guangzhou University of Chinese Medicine,
Hunan University of Traditional Chinese Medicine,
Beijing University of Chinese Medicine,
Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine
ORCID:
0000-0002-6118-2309
Observed ORCID:
0000-0002-6118-2309
OpenAlex ID:
A5089475914
Effects of icariin and curcumol on autophagy, ferroptosis, and lipid metabolism based on miR ‐7/ m‐TOR / SREBP1 pathway on prostate cancer
2022
·
Wenjing Xu
, Jin Ding
, et al.
·
BioFactors
·
48
Luteolin induces ferroptosis in prostate cancer cells by promoting TFEB nuclear translocation and increasing ferritinophagy
2023
·
Wei Fu
, Lei Xu
, et al.
·
The Prostate
·
42
Curcumol inhibits the malignant progression of prostate cancer and regulates the PDK1/AKT/mTOR pathway by targeting miR‑9
2021
·
Wen Sheng
, Wenjing Xu
, et al.
·
Oncology Reports
·
33
PDF
Exploring the Pharmacological Mechanisms of Xihuang Pills Against Prostate Cancer via Integrating Network Pharmacology and Experimental Validation In Vitro and In Vivo
2022
·
Yongrong Wu
, Xujun You
, et al.
·
Frontiers in Pharmacology
·
31
PDF
Enhancement of anticancer activity of docetaxel by combination with Fuzheng Yiliu decoction in a mouse model of castration-resistant prostate cancer
2019
·
Wei Fu
, Zhiming Hong
, et al.
·
Biomedicine & Pharmacotherapy
·
27
PDF
Application of network pharmacology and molecular docking to elucidate the potential mechanism of Astragalus–Scorpion against prostate cancer
2021
·
Litong Wu
, Ying Chen
, et al.
·
Andrologia
·
24
PDF
Astragalus–Scorpion Drug Pair Inhibits the Development of Prostate Cancer by Regulating GDPD4-2/PI3K/AKT/mTOR Pathway and Autophagy
2022
·
Xujun You
, Yongrong Wu
, et al.
·
Frontiers in Pharmacology
·
22
PDF
Astragaloside IV-PESV inhibits prostate cancer tumor growth by restoring gut microbiota and microbial metabolic homeostasis via the AGE-RAGE pathway
2024
·
Xujun You
, Junfeng Qiu
, et al.
·
BMC Cancer
·
20
PDF
Curcumol Inhibits the Development of Prostate Cancer by miR-125a/STAT3 Axis
2022
·
Wen Sheng
, Jin Ding
, et al.
·
Evidence-based Complementary and Alternative Medicine
·
19
PDF
Quercetin in Tonglong Qibi decoction ameliorates testosterone‐induced benign prostatic hyperplasia in rats by regulating Nrf2 signalling pathways and oxidative stress
2022
·
Wei Fu
, Shuchao Chen
, et al.
·
Andrologia
·
12
Astragaloside IV-PESV facilitates pyroptosis by enhancing palmitoylation of GSDMD protein mediated by ZDHHC1
2025
·
Xujun You
, Honghan Li
, et al.
·
Naunyn-Schmiedeberg s Archives of Pharmacology
·
8
Feasibility study of lncRNA DHRS4-AS1 sponge miR-222-3p in the diagnosis of thyroid cancer
2024
·
Shuai Xu
, Xinyi Zheng
, et al.
·
Endokrynologia Polska
·
5
PDF
Exploring the mechanism of action of Sparganii Rhizoma-Curcumae Rhizoma for in treating castration-resistant prostate cancer: a network-based pharmacology and experimental validation study
2024
·
Litong Wu
, Haijun Chen
, et al.
·
Scientific Reports
·
5
PDF
Hedyotis diffusae herba -Scutellaria Barbata herba drug pair suppresses prostate cancer by inducing apoptosis
2025
·
Junfeng Qiu
, Litong Wu
, et al.
·
Scientific Reports
·
4
PDF
Combination of astragalus polysaccharide with Diosbulbin B exerts an enhanced antitumor effect in BRAFmut papillary thyroid cancer with decreased liver toxicity
2025
·
Shuai Xu
, Qi Liang
, et al.
·
Cancer Cell International
·
4
PDF
Neurobiology of Premature Ejaculation: Serotonergic Mechanisms and Emerging Therapeutic Insights
2025
·
Junfeng Qiu
, Biao Wang
, et al.
·
Andrologia
·
4
Xihuang pills targeting the Warburg effect through inhibition of the Wnt/β-catenin pathway in prostate cancer
2024
·
Fengxia Lin
, Yan Long
, et al.
·
Heliyon
·
4
Astragaloside IV-PESV Repressed T Cell Immunosuppression by Inhibiting PD-L1 Expression in Prostate Cancer through STAT3 Pathway
2023
·
Xujun You
, Junfeng Qiu
, et al.
·
Journal of Food Biochemistry
·
3
PDF
Based on Network Pharmacology‐Quercetin, a Component of Fuzheng Yiliu Decoction Suppressed Prostate Cancer by Regulating PI3K/AKT Pathway
2023
·
Wei Fu
, Lei Xu
, et al.
·
Andrologia
·
3
PDF
Four types of RNA modification writers predict the prognosis of prostate cancer
2022
·
Wei Fu
, Jin Ding
, et al.
·
Andrologia
·
3
Corrigendum to “Xihuang pills targeting the Warburg effect through inhibition of the Wnt/β-catenin pathway in prostate cancer” [Heliyon Volume 10, Issue 12, June 2024, Article e32914]
2025
·
Fengxia Lin
, Yan Long
, et al.
·
Heliyon
PDF
Corrigendum: Astragalus–Scorpion drug pair inhibits the development of prostate cancer by regulating GDPD4-2/PI3K/AKT/mTOR pathway and autophagy
2025
·
Xujun You
, Yongrong Wu
, et al.
·
Frontiers in Pharmacology
Author Correction: Exploring the mechanism of action of Sparganii Rhizoma-Curcumae Rhizoma for in treating castration-resistant prostate cancer: a network-based pharmacology and experimental validation study
2024
·
Litong Wu
, Haijun Chen
, et al.
·
Scientific Reports
PDF
Candidate biomarkers for diagnosis and prognosis of prostate cancer based on bioinformatics methods
2022
·
Shuchao Chen
, Yongshun Li
, et al.
·
Research Square
PDF
A Network Pharmacology Approach and Molecular Docking Technology to Uncover the Potential Molecular Mechanism of Astragalus -Scorpion on Prostate Cancer
2021
·
Litong Wu
, Ying Chen
, et al.
·
Research Square
PDF
Show more works
View as search
Works count:
26
Citation count:
321
H-index:
10
I10-index:
10
Year
Topic
Type